The three PBMs accounted for about 60 percent of pro forma U.S. retail mail, long-term care and specialty equivalent prescription claims in 2019.
Changes in nonspecialty drug spending:
CVS Health: -4.9 percent
Express Scripts: -5 percent
Prime Therapeutics: -0.8 percent
This is the third consecutive year that spending growth in nonspecialty drugs declined by mid-single digits, according to pharmacy news site Drug Channels. The decline can be attributed to deeper commercial rebates on brand-name drugs, deflation in generics and a small increase in generic dispensing rates.
Changes in specialty drug spending:
CVS Health: +9.3 percent
Express Scripts: +11.6 percent
Prime Therapeutics: +14.1 percent
A majority of specialty drug-spending growth can be attributed to the growth in the number of people being treated and the number of prescriptions being dispensed, Drug Channels reported.
Overall change in drug spending:
CVS Health: +1.4 percent
Express Scripts: +2.3 percent
Prime Therapeutics: +4.7 percent
Read the full report here.
More articles on pharmacy:
FDA warns of potential drug interaction with remdesivir
Steroid could reduce COVID-19 deaths: 5 things to know
Walmart buys prescription management tech from CareZone
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
